Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients
Sung Chul Park, Yoon Tae Jeen
Cells (2019) Vol. 8, Iss. 5, pp. 404-404
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
Linshan Duan, Shu-Yu Cheng, Long Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 89
Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
Sara Jarmakiewicz-Czaja, Magdalena Zielińska, Aneta Sokal, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2388-2388
Open Access | Times Cited: 62
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?
Bram Verstockt, Brian Bressler, Helena Martínez-Lozano, et al.
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1370-1382
Closed Access | Times Cited: 41
A Broad m6A Modification Landscape in Inflammatory Bowel Disease
Kai Nie, Jun Yi, Yuanyuan Yang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 39
Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
Yaxi Zhou, Diandian Wang, Wenjie Yan
Nutrients (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 36
Molecular Foundations of Inflammatory Diseases: Insights into Inflammation and Inflammasomes
Mi Eun Kim, Jun Sik Lee
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 1, pp. 469-484
Open Access | Times Cited: 9
Unravelling the Oral–Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon L. Allison, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 8, pp. 1319-1341
Open Access | Times Cited: 9
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date
Alessandro Giammona, Bruno G. Galuzzi, Elena Imperia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 413-413
Open Access | Times Cited: 1
Role of Nutrition in the Management of Inflammatory Bowel Disease
Khalid Nawaz, Atsushi Ito, Muneeb Ullah, et al.
Recent Progress in Nutrition (2025) Vol. 05, Iss. 01, pp. 1-76
Closed Access | Times Cited: 1
The Role of Autophagy in Inflammatory Bowel Disease
Bo‐Zong Shao, Yi Yao, Junshan Zhai, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 55
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
Lidiya V. Boldyreva, Maryana V. Morozova, Snezhanna S. Saydakova, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11682-11682
Open Access | Times Cited: 47
Roles of microRNAs in inflammatory bowel disease
HyunTaek Jung, Jae‐Seok Kim, Keum Hwa Lee, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 8, pp. 2112-2123
Open Access | Times Cited: 43
HucMSC-Ex carrying miR-203a-3p.2 ameliorates colitis through the suppression of caspase11/4-induced macrophage pyroptosis
Yuting Xu, Xiaohua Tang, Anning Fang, et al.
International Immunopharmacology (2022) Vol. 110, pp. 108925-108925
Closed Access | Times Cited: 32
How autophagy, a potential therapeutic target, regulates intestinal inflammation
Shuang-Lan Chen, Chunmeng Li, Wei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Pathogenesis of Perianal Fistulising Crohn’s Disease: Current Knowledge, Gaps in Understanding, and Future Research Directions
Siyan Cao, Marco Colonna, Parakkal Deepak
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 6, pp. 1010-1022
Closed Access | Times Cited: 14
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects
C. Raman Suri, Babita Pande, Tarun Sahu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3977-3977
Open Access | Times Cited: 6
A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn’s Disease
Shekhar Swaroop, Sudheer K. Vuyyuru, Bhaskar Kante, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
Giuseppe Privitera, Daniela Pugliese, Gian Ludovico Rapaccini, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 853-853
Open Access | Times Cited: 32
Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
Alexander S. Dowdell, Sean P. Colgan
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 708-708
Open Access | Times Cited: 32
A Potential Role for Gut Microbes in Mediating Effects of Omega-3 Fatty Acids in Inflammatory Bowel Diseases: A Comprehensive Review
N Arjomand Fard, Michael Bording‐Jorgensen, Eytan Wine
Current Microbiology (2023) Vol. 80, Iss. 11
Closed Access | Times Cited: 12
Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci
Myunghee Hong, Byong Duk Ye, Suk‐Kyun Yang, et al.
Journal of Crohn s and Colitis (2018) Vol. 12, Iss. 6, pp. 730-741
Open Access | Times Cited: 34
Prenatal Maternal Stress Exacerbates Experimental Colitis of Offspring in Adulthood
Yue Sun, Runxiang Xie, Li Lü, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 27
Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
Sudheer K. Vuyyuru, Saurabh Kedia, Pabitra Sahu, et al.
JGH Open (2022) Vol. 6, Iss. 2, pp. 100-111
Open Access | Times Cited: 19
The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease
Ziyue Liu, Yaqin Zhang, Tao Jin, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109466-109466
Open Access | Times Cited: 18
Loss of claudin-3 expression increases colitis risk by promoting Gut Dysbiosis
Rizwan Ahmad, Balawant Kumar, Ishwor Thapa, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top